Resources for Pharmacy Compounding, Sterile Drug Preparation, and Hazardous Drug Preparation
Over a decade ago, the United States Pharmacopeia issued Chapter 797 "Pharmaceutical Compounding – Sterile Preparations" (USP <797>), which provides the guidelines, procedures and compliance requirements for compounding sterile preparations and sets the standards that apply to all settings in which sterile preparations are compounded. With the addition of USP <800> "Hazardous Drugs – Handling in Healthcare Settings," this resource center has been prepared to help you stay current on the latest issues about aseptic preparation of parenteral hazardous and non-hazardous drug products.
- CETA Applications Guides
Covering topics from pharmaceutical compounding to general biosafety cabinet information, these guides are available to CETA members as a free download and to others for a nominal fee.
Hazardous Drug Preparation
- Free Webinar: USP <800> Impact to Engineering Controls
Learn how USP <800> will impact primary and secondary engineering controls (e.g., biological safety cabinets, clean rooms, etc.). The webinar is intended to inform facilities that need to implement the new standards.
- Frequently Asked Questions about USP <800>
Answers to questions from attendees of the above webinar for the benefit of all who are preparing to implement the proposed USP <800> guidelines.
- ASHP Guidelines on Handling Hazardous Drugs
Includes information from the recommendations issued in the 2004 NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazarous Drugs in Health Care Setting.
- 2004 NIOSH Alert
View the NIOSH publication Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Setting and other information from the CDC
- Safe Handling of Hazardous Drugs: Reviewing Standards for Work Protection
Article published in March 2011 in Pharmacy Practice News by Luci A Power, MS, RPh and Martha Polovich, PhD, RN, AOCN.
Overview of OSHA standards and standard interpretations for handling hazardous drugs. Also includes state standards related to hazardous drugs.
- Connor TH, Anderson RW, Sessink PJ, Broadfield L, Power LA; Surface Contamination with Antineoplastic Agents in Six Cancer Treatment Centers in Canada and the United States; Am J Health Syst Pharm 1999 Jul 15;56(124): 1427-32 (abstract only)
This study provides evidence from a sample of facilities indicating that antineoplastic agents were detected on surfaces in pharmacy drug preparation and administration areas in cancer treatment centers, and includes a brief overview of the potential risks of exposure.
Compounded Sterile Preparation
Guidelines and Standards for Laboratory Safety & Hazardous Drug Preparation
Barrier Isolator and Glovebox Technology